Previous research has revealed that the expression level of MEIS1D27, a truncated splicing variant of MEIS1, decreased in primary colorectal cancer samples, insinuating tumor suppressive effect of MEIS1,34 which is consistent with our results obtained in CRC samples from public datasets, especially in GSE69657 composed of oxaliplatin resistant CRC patients. Here, MEIS1 is linked to neoplasm.